Pimstone Simon N.'s Form 4 filing
Xenon Pharmaceuticals Inc. (XENE) · filed Aug 16, 2022
- Accession no.
- 0001209191-22-046015
- Filed
- Aug 16, 2022
- Trade date
- Aug 12-16, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 6 non-derivative transactions and 0 derivative transactions. Open-market sales total $6.78M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Pimstone Simon N.CIK 0001620084 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 12, 2022 | Common Shares | SSaleDisposed | −43,135 | $37.91 | −$1,635,247.85 | 140,000 | Direct | |
| Aug 12, 2022 | Common Shares | SSaleDisposed | −47,000 | $38.60 | −$1,814,200 | 93,000 | Direct | |
| Aug 12, 2022 | Common Shares | SSaleDisposed | −1,000 | $39.15 | −$39,150 | 92,000 | Direct | |
| Aug 15, 2022 | Common Shares | SSaleDisposed | −33,942 | $37.76 | −$1,281,649.92 | 58,058 | Direct | |
| Aug 16, 2022 | Common Shares | SSaleDisposed | −32,058 | $38.29 | −$1,227,500.82 | 26,000 | Direct | |
| Aug 16, 2022 | Common Shares | SSaleDisposed | −20,000 | $38.87 | −$777,400 | 6,000 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.